ALLENDENZ Trademark

Trademark Overview

On Friday, March 6, 2020, a trademark application was filed for ALLENDENZ with the United States Patent and Trademark Office. The USPTO has given the ALLENDENZ trademark a serial number of 79282136. The federal status of this trademark filing is REGISTERED as of Tuesday, December 22, 2020. This trademark is owned by Seqirus UK Limited. The ALLENDENZ trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
allendenz

General Information

Serial Number79282136
Word MarkALLENDENZ
Filing DateFriday, March 6, 2020
Status700 - REGISTERED
Status DateTuesday, December 22, 2020
Registration Number6224584
Registration DateTuesday, December 22, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Name/Portrait Description and/or Consent StatementThe name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeqirus UK Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameSeqirus UK Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameSeqirus UK Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Friday, January 5, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, June 8, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, April 28, 2021IRREGULARITY FROM IB EXAMINED BY MPU
Monday, April 26, 2021IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Tuesday, March 30, 2021GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, March 30, 2021GENERIC MADRID TRANSACTION CREATED
Monday, March 22, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 22, 2020REGISTERED-PRINCIPAL REGISTER
Sunday, October 18, 2020NOTIFICATION PROCESSED BY IB
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 17, 2020REFUSAL PROCESSED BY IB
Monday, June 29, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 29, 2020REFUSAL PROCESSED BY MPU
Saturday, May 30, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 29, 2020NON-FINAL ACTION WRITTEN
Tuesday, May 26, 2020ASSIGNED TO EXAMINER
Tuesday, April 7, 2020APPLICATION FILING RECEIPT MAILED
Friday, April 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 2, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

allendenz human vaccines